Table 5.
List of unreported pathways and possible hypotheses
| Potential tumor pathways | Possible hypotheses for the potential pathways interplay in cancer process |
|---|---|
| hsa05145 Toxoplasmosis | This pathway might be considered as a potential pathogen in cancer patients who have clinical syndromes, especially lymphadenopathy and is possible to be affected by EBV, HPV16, HPV18 and KSHV |
| hsa04062 chemokine signaling pathway | This pathway is probably potential for cervical cancer process and may affect the cell survival, apoptosis and other mechanisms after viral product perturbation |
| hsa05164 influenza A | These pathways might be potential with the perturbations on human immune system, especially the ones which contain IFN regulatory factors are possible to be affected by KSHV and play important roles in signaling tumor types |
| hsa05162 measles | |
| hsa04620 toll-like receptor signaling pathway | |
| hsa05133 pertussis | |
| hsa04350 TGF-beta signaling pathway | |
| hsa04380 osteoclast differentiation | |
| hsa04622 RIG-I-like receptor signaling pathway | |
| hsa05142 Chagas disease (American trypanosomiasis) | |
| hsa04010 MAPK signaling pathway | |
| hsa05140 leishmaniasis | |
| hsa04390 hippo signaling pathway | |
| hsa05016 Huntington’s disease | |
| hsa04950 maturity onset diabetes of the young | |
| hsa00561 glycerolipid metabolism | These pathways might be essential for EBV mediated transformations or disease process |
| hsa00565 ether lipid metabolism | |
| hsa00564 glycerophospholipid tabolism | |
| hsa04666 Fc gamma R-mediated phagocytosis | |
| hsa04975 fat digestion and absorption | |
| hsa00600 sphingolipid metabolism |